{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:47:25Z","timestamp":1792104445101,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Medicine, University of Illinois at Chicago"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY001792"],"award-info":[{"award-number":["P30EY001792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY001792"],"award-info":[{"award-number":["P30EY001792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background: Intrinsically photosensitive retinal ganglion cells (ipRGCs) control non-visual light responses (e.g. pupillary light reflex and circadian entrainment). Patients with diabetic retinopathy (DR) show reduced ipRGC function, as inferred by abnormalities in the post illumination pupil response (PIPR). We explored whether ipRGC function in DR is associated with circadian outputs and sleep\/wake behavior. Methods: Forty-five participants (15 without diabetes, 15 with type 2 diabetes (T2D) and no DR, 15 with T2D and DR) participated. ipRGC function was inferred from the PIPR (pupil size following stimulus offset). Circadian outputs were melatonin amplitude (overnight urinary 6-sulfatoxymelatonin (aMT6s)) and timing (dim light melatonin onset (DLMO)), and evening salivary cortisol levels. Sleep\/wake patterns were measured with wrist actigraphy and insomnia symptoms were assessed subjectively. Results: Patients with T2D and DR had smaller PIPR and lower urinary aMT6s than other groups (p\u2009&lt;\u20090.001). In adjusted regression models, smaller PIPR was associated with lower urinary aMT6s (\u03b2\u2009=\u20094.552, p\u2009=\u20090.005). Patients with DR were more likely to have no detectable DLMO (p\u2009=\u20090.049), higher evening salivary cortisol, greater insomnia symptoms and greater sleep variability compared to other groups. Sleep duration, efficiency and rest-activity rhythms were similar. Conclusion: Reduced ipRGC function in DR is associated with circadian dysregulation and sleep disturbances, although a\u00a0causal relationship cannot be established in this cross-sectional study. Prospective mechanistic and intervention studies examining circadian and sleep health in these patients are warranted.<\/jats:p>","DOI":"10.1038\/s41598-020-58205-1","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T11:02:58Z","timestamp":1580468578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Relationship between Intrinsically Photosensitive Ganglion Cell Function and Circadian Regulation in Diabetic Retinopathy"],"prefix":"10.1038","volume":"10","author":[{"given":"Sirimon","family":"Reutrakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Y.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Priyadarshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C.","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie K.","family":"Danielson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben S.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Baynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade J.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jason","family":"McAnany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"58205_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","volume":"304","author":"X Zhang","year":"2010","unstructured":"Zhang, X. et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. Jama 304, 649\u2013656, https:\/\/doi.org\/10.1001\/jama.2010.1111 (2010).","journal-title":"Jama"},{"key":"58205_CR2","unstructured":"National Eye Institute. Diabetic Retinopathy, https:\/\/nei.nih.gov\/eyedata\/diabetic (2017)."},{"key":"58205_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1444-0938.2012.00733.x","volume":"95","author":"AJ Adams","year":"2012","unstructured":"Adams, A. J. & Bearse, M. A. Jr. Retinal neuropathy precedes vasculopathy in diabetes: a function-based opportunity for early treatment intervention? Clinical & experimental optometry 95, 256\u2013265, https:\/\/doi.org\/10.1111\/j.1444-0938.2012.00733.x (2012).","journal-title":"Clinical & experimental optometry"},{"key":"58205_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","volume":"139","author":"SK Lynch","year":"2017","unstructured":"Lynch, S. K. & Abramoff, M. D. Diabetic retinopathy is a neurodegenerative disorder. Vision research 139, 101\u2013107, https:\/\/doi.org\/10.1016\/j.visres.2017.03.003 (2017).","journal-title":"Vision research"},{"key":"58205_CR5","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1167\/iovs.16-21168","volume":"58","author":"EA Obara","year":"2017","unstructured":"Obara, E. A., Hannibal, J., Heegaard, S. & Fahrenkrug, J. Loss of Melanopsin-Expressing Retinal Ganglion Cells in Patients With Diabetic Retinopathy. Investigative ophthalmology & visual science 58, 2187\u20132192, https:\/\/doi.org\/10.1167\/iovs.16-21168 (2017).","journal-title":"Investigative ophthalmology & visual science"},{"key":"58205_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/01658100600599527","volume":"30","author":"Y Yang","year":"2006","unstructured":"Yang, Y., Yu, Y. & Yao, K. Pupillary Dysfunction in Type 2 Diabetes Mellitus to Refine the Early Diagnosis of Diabetic Autonomic Neuropathy. Neuro-Ophthalmology 30, 17\u201321 (2006).","journal-title":"Neuro-Ophthalmology"},{"key":"58205_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1475-925x-9-26","volume":"9","author":"GL Ferrari","year":"2010","unstructured":"Ferrari, G. L. et al. Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomedical engineering online 9, 26, https:\/\/doi.org\/10.1186\/1475-925x-9-26 (2010).","journal-title":"Biomedical engineering online"},{"key":"58205_CR8","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1111\/j.1755-3768.2011.02226.x","volume":"90","author":"B Feigl","year":"2012","unstructured":"Feigl, B. et al. The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta ophthalmologica 90, e230\u2013234, https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02226.x (2012).","journal-title":"Acta ophthalmologica"},{"key":"58205_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep44987","volume":"7","author":"JC Park","year":"2017","unstructured":"Park, J. C. et al. Pupillary responses in non-proliferative diabetic retinopathy. Sci Rep 7, 44987, https:\/\/doi.org\/10.1038\/srep44987 (2017).","journal-title":"Sci Rep"},{"key":"58205_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1056\/NEJM199701163360306","volume":"336","author":"A Brzezinski","year":"1997","unstructured":"Brzezinski, A. Melatonin in humans. N Engl J Med 336, 186\u2013195, https:\/\/doi.org\/10.1056\/NEJM199701163360306 (1997).","journal-title":"N Engl J Med"},{"key":"58205_CR11","first-page":"4317","volume":"7","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes. Int. J. Clin. Exp. Pathol 7, 4317\u20134322 (2014).","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"58205_CR12","doi-asserted-by":"crossref","unstructured":"Hikichi, T., Tateda, N. & Miura, T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin. Ophthalmol 5, 655-660, doi:10.2147\/OPTH.S19559 [doi];opth-5-655 [pii] (2011).","DOI":"10.2147\/OPTH.S19559"},{"key":"58205_CR13","doi-asserted-by":"crossref","unstructured":"Peschke, E. et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J. Pineal Res 40, 135-143, doi:JPI287 [pii];10.1111\/j.1600-079X.2005.00287.x [doi] (2006).","DOI":"10.1111\/j.1600-079X.2005.00287.x"},{"key":"58205_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/07420528.2016.1278382","volume":"34","author":"S Reutrakul","year":"2017","unstructured":"Reutrakul, S. et al. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes. Chronobiol. Int 34, 382\u2013392, https:\/\/doi.org\/10.1080\/07420528.2016.1278382 (2017).","journal-title":"Chronobiol. Int"},{"key":"58205_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.sleep.2018.10.018","volume":"54","author":"S Ba-Ali","year":"2019","unstructured":"Ba-Ali, S. et al. Assessment of diurnal melatonin, cortisol, activity, and sleep-wake cycle in patients with and without diabetic retinopathy. Sleep medicine 54, 35\u201342, https:\/\/doi.org\/10.1016\/j.sleep.2018.10.018 (2019).","journal-title":"Sleep medicine"},{"key":"58205_CR16","unstructured":"Lee, S. W., Ng, K. Y. & Chin, W. K. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med. Rev, doi:S1087-0792(16)00017-4 [pii];10.1016\/j.smrv.2016.02.001 [doi] (2016)."},{"key":"58205_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/jsr.12554","volume":"26","author":"A Manodpitipong","year":"2017","unstructured":"Manodpitipong, A. et al. Night-shift work is associated with poorer glycaemic control in patients with type 2 diabetes. J Sleep Res 26, 764\u2013772, https:\/\/doi.org\/10.1111\/jsr.12554 (2017).","journal-title":"J Sleep Res"},{"key":"58205_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/pchj.182","volume":"6","author":"T Kantermann","year":"2017","unstructured":"Kantermann, T. & Burgess, H. J. Average mid-sleep time as a proxy for circadian phase. PsyCh journal 6, 290\u2013291, https:\/\/doi.org\/10.1002\/pchj.182 (2017).","journal-title":"PsyCh journal"},{"key":"58205_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jsr.12393","volume":"25","author":"S Chontong","year":"2016","unstructured":"Chontong, S., Saetung, S. & Reutrakul, S. Higher sleep variability is associated with poorer glycaemic control in patients with type 1 diabetes. J Sleep Res 25, 438\u2013444, https:\/\/doi.org\/10.1111\/jsr.12393 (2016).","journal-title":"J Sleep Res"},{"issue":"6","key":"58205_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/pedi.12689","volume":"19","author":"Niral J Patel","year":"2018","unstructured":"Patel, N. J. et al. Sleep habits in adolescents with type 1 diabetes: Variability in sleep duration linked with glycemic control. Pediatr Diabetes, https:\/\/doi.org\/10.1111\/pedi.12689 (2018).","journal-title":"Pediatric Diabetes"},{"key":"58205_CR21","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.0808180106","volume":"106","author":"FA Scheer","year":"2009","unstructured":"Scheer, F. A., Hilton, M. F., Mantzoros, C. S. & Shea, S. A. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. USA 106, 4453\u20134458, https:\/\/doi.org\/10.1073\/pnas.0808180106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58205_CR22","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2337\/db13-1546","volume":"63","author":"R Leproult","year":"2014","unstructured":"Leproult, R., Holmback, U. & Van Cauter, E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes 63, 1860\u20131869, https:\/\/doi.org\/10.2337\/db13-1546 (2014).","journal-title":"Diabetes"},{"key":"58205_CR23","doi-asserted-by":"crossref","unstructured":"Peschke, E. & Muhlbauer, E. New evidence for a role of melatonin in glucose regulation. Best. Pract. Res. Clin. Endocrinol. Metab 24, 829-841, doi:S1521-690X(10)00116-8 [pii];10.1016\/j.beem.2010.09.001 [doi] (2010).","DOI":"10.1016\/j.beem.2010.09.001"},{"key":"58205_CR24","doi-asserted-by":"crossref","unstructured":"McMullan, C. J., Schernhammer, E. S., Rimm, E. B., Hu, F. B. & Forman, J. P. Melatonin secretion and the incidence of type 2 diabetes. JAMA 309, 1388\u20131396, doi:1674239 [pii];10.1001\/jama.2013.2710 [doi] (2013).","DOI":"10.1001\/jama.2013.2710"},{"key":"58205_CR25","doi-asserted-by":"crossref","unstructured":"McMullan, C. J., Curhan, G. C., Schernhammer, E. S. & Forman, J. P. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am. J. Epidemiol 178, 231\u2013238, doi:kws470 [pii];10.1093\/aje\/kws470 [doi] (2013).","DOI":"10.1093\/aje\/kws470"},{"key":"58205_CR26","first-page":"3082","volume":"84","author":"L Plat","year":"1999","unstructured":"Plat, L. et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin. Endocrinol. Metab 84, 3082\u20133092 (1999).","journal-title":"J Clin. Endocrinol. Metab"},{"key":"58205_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.14740\/jocmr2754w","volume":"8","author":"T Tsunoda","year":"2016","unstructured":"Tsunoda, T. et al. The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial. Journal of clinical medicine research 8, 878\u2013887, https:\/\/doi.org\/10.14740\/jocmr2754w (2016).","journal-title":"Journal of clinical medicine research"},{"issue":"1","key":"58205_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clnu.2017.12.004","volume":"38","author":"Fariba Raygan","year":"2019","unstructured":"Raygan, F., Ostadmohammadi, V., Bahmani, F., Reiter, R. J. & Asemi, Z. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clinical nutrition (Edinburgh, Scotland), https:\/\/doi.org\/10.1016\/j.clnu.2017.12.004 (2017).","journal-title":"Clinical Nutrition"},{"key":"58205_CR29","unstructured":"Hussain, S. A. et al. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi. Med J 27, 1483-1488, doi:20060160\u2019 [pii] (2006)."},{"key":"58205_CR30","doi-asserted-by":"crossref","unstructured":"Garfinkel, D. et al. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr. Obes 4, 307-313, doi:10.2147\/DMSO.S23904 [doi];dmso-4-307 [pii] (2011).","DOI":"10.2147\/DMSO.S23904"},{"key":"58205_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1600-079X.2006.00353.x","volume":"41","author":"HM Kadhim","year":"2006","unstructured":"Kadhim, H. M. et al. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res 41, 189\u2013193, https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00353.x (2006).","journal-title":"J Pineal Res"},{"key":"58205_CR32","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/s0140-6736(15)60031-9","volume":"386","author":"SW Lockley","year":"2015","unstructured":"Lockley, S. W. et al. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet 386, 1754\u20131764, https:\/\/doi.org\/10.1016\/s0140-6736(15)60031-9 (2015).","journal-title":"Lancet"},{"key":"58205_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroscience.2015.06.046","volume":"303","author":"W Pack","year":"2015","unstructured":"Pack, W., Hill, D. D. & Wong, K. Y. Melatonin modulates M4-type ganglion-cell photoreceptors. Neuroscience 303, 178\u2013188, https:\/\/doi.org\/10.1016\/j.neuroscience.2015.06.046 (2015).","journal-title":"Neuroscience"},{"key":"58205_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0748730409343767","volume":"24","author":"S Weng","year":"2009","unstructured":"Weng, S., Wong, K. Y. & Berson, D. M. Circadian modulation of melanopsin-driven light response in rat ganglion-cell photoreceptors. Journal of biological rhythms 24, 391\u2013402, https:\/\/doi.org\/10.1177\/0748730409343767 (2009).","journal-title":"Journal of biological rhythms"},{"key":"58205_CR35","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4239\/wjd.v6.i6.868","volume":"6","author":"S Surani","year":"2015","unstructured":"Surani, S., Brito, V., Surani, A. & Ghamande, S. Effect of diabetes mellitus on sleep quality. World journal of diabetes 6, 868\u2013873, https:\/\/doi.org\/10.4239\/wjd.v6.i6.868 (2015).","journal-title":"World journal of diabetes"},{"key":"58205_CR36","first-page":"233","volume":"39","author":"MD Davis","year":"1998","unstructured":"Davis, M. D. et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Investigative ophthalmology & visual science 39, 233\u2013252 (1998).","journal-title":"Investigative ophthalmology & visual science"},{"key":"58205_CR37","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1167\/iovs.11-7586","volume":"52","author":"JC Park","year":"2011","unstructured":"Park, J. C. et al. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. Investigative ophthalmology & visual science 52, 6624\u20136635, https:\/\/doi.org\/10.1167\/iovs.11-7586 (2011).","journal-title":"Investigative ophthalmology & visual science"},{"key":"58205_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/iovs.15-18181","volume":"57","author":"JC Park","year":"2016","unstructured":"Park, J. C., Moss, H. E. & McAnany, J. J. The Pupillary Light Reflex in Idiopathic Intracranial. Hypertension. Investigative ophthalmology & visual science 57, 23\u201329, https:\/\/doi.org\/10.1167\/iovs.15-18181 (2016).","journal-title":"Hypertension. Investigative ophthalmology & visual science"},{"key":"58205_CR39","doi-asserted-by":"publisher","first-page":"e33836","DOI":"10.1371\/journal.pone.0033836","volume":"7","author":"H Klerman","year":"2012","unstructured":"Klerman, H. et al. Analysis method and experimental conditions affect computed circadian phase from melatonin data. PLoS One 7, e33836, https:\/\/doi.org\/10.1371\/journal.pone.0033836 (2012).","journal-title":"PLoS One"},{"key":"58205_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/074873002129002474","volume":"17","author":"EB Klerman","year":"2002","unstructured":"Klerman, E. B., Gershengorn, H. B., Duffy, J. F. & Kronauer, R. E. Comparisons of the variability of three markers of the human circadian pacemaker. Journal of biological rhythms 17, 181\u2013193, https:\/\/doi.org\/10.1177\/074873002129002474 (2002).","journal-title":"Journal of biological rhythms"},{"key":"58205_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0748730404273983","volume":"20","author":"S Benloucif","year":"2005","unstructured":"Benloucif, S. et al. Stability of melatonin and temperature as circadian phase markers and their relation to sleep times in humans. Journal of biological rhythms 20, 178\u2013188, https:\/\/doi.org\/10.1177\/0748730404273983 (2005).","journal-title":"Journal of biological rhythms"},{"key":"58205_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/074873049701200507","volume":"12","author":"A Voultsios","year":"1997","unstructured":"Voultsios, A., Kennaway, D. J. & Dawson, D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. Journal of biological rhythms 12, 457\u2013466, https:\/\/doi.org\/10.1177\/074873049701200507 (1997).","journal-title":"Journal of biological rhythms"},{"key":"58205_CR43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1176\/ajp.142.9.1065","volume":"142","author":"PM Burke","year":"1985","unstructured":"Burke, P. M. et al. Correlation between serum and salivary cortisol levels in depressed and nondepressed children and adolescents. The American journal of psychiatry 142, 1065\u20131067, https:\/\/doi.org\/10.1176\/ajp.142.9.1065 (1985).","journal-title":"The American journal of psychiatry"},{"key":"58205_CR44","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1378\/chest.11-0448","volume":"140","author":"YMRM Estrada","year":"2011","unstructured":"Estrada, Y. M. R. M. & Orlander, P. R. Salivary cortisol can replace free serum cortisol measurements in patients with septic shock. Chest 140, 1216\u20131222, https:\/\/doi.org\/10.1378\/chest.11-0448 (2011).","journal-title":"Chest"},{"key":"58205_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin, C. M., Belleville, G., Belanger, L. & Ivers, H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34, 601\u2013608 (2011).","journal-title":"Sleep"},{"key":"58205_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/sleep\/29.3.367","volume":"29","author":"D Zou","year":"2006","unstructured":"Zou, D., Grote, L., Peker, Y., Lindblad, U. & Hedner, J. Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. Sleep 29, 367\u2013374 (2006).","journal-title":"Sleep"},{"issue":"9","key":"58205_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00592-018-1166-3","volume":"55","author":"Sunee Saetung","year":"2018","unstructured":"Saetung, S. et al. The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes. Acta Diabetol, https:\/\/doi.org\/10.1007\/s00592-018-1166-3 (2018).","journal-title":"Acta Diabetologica"},{"key":"58205_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0006-3223(95)00370-3","volume":"40","author":"EJ van Someren","year":"1996","unstructured":"van Someren, E. J. et al. Circadian rest-activity rhythm disturbances in Alzheimer\u2019s disease. Biological psychiatry 40, 259\u2013270, https:\/\/doi.org\/10.1016\/0006-3223(95)00370-3 (1996).","journal-title":"Biological psychiatry"},{"key":"58205_CR49","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.mex.2016.05.006","volume":"3","author":"C Blume","year":"2016","unstructured":"Blume, C., Santhi, N. & Schabus, M. \u2018nparACT\u2019 package for R: A free software tool for the non-parametric analysis of actigraphy data. MethodsX 3, 430\u2013435, https:\/\/doi.org\/10.1016\/j.mex.2016.05.006 (2016).","journal-title":"MethodsX"},{"key":"58205_CR50","doi-asserted-by":"publisher","first-page":"6069730","DOI":"10.1155\/2017\/6069730","volume":"2017","author":"F Ishibashi","year":"2017","unstructured":"Ishibashi, F. et al. The Preferential Impairment of Pupil Constriction Stimulated by Blue Light in Patients with Type 2 Diabetes without Autonomic Neuropathy. Journal of diabetes research 2017, 6069730, https:\/\/doi.org\/10.1155\/2017\/6069730 (2017).","journal-title":"Journal of diabetes research"},{"key":"58205_CR51","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","volume":"17","author":"EL Feldman","year":"1994","unstructured":"Feldman, E. L. et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17, 1281\u20131289 (1994).","journal-title":"Diabetes Care"},{"key":"58205_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/cphy.c140014","volume":"5","author":"DH McDougal","year":"2015","unstructured":"McDougal, D. H. & Gamlin, P. D. Autonomic control of the eye. Comprehensive Physiology 5, 439\u2013473, https:\/\/doi.org\/10.1002\/cphy.c140014 (2015).","journal-title":"Comprehensive Physiology"},{"key":"58205_CR53","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/europace\/euv015","volume":"17","author":"R Sassi","year":"2015","unstructured":"Sassi, R. et al. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm. Society. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 17, 1341\u20131353, https:\/\/doi.org\/10.1093\/europace\/euv015 (2015).","journal-title":"Society. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"},{"key":"58205_CR54","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/oxfordjournals.eurheartj.a014868","volume":"17","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","year":"1996","unstructured":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. European heart journal 17, 354\u2013381 (1996).","journal-title":"European heart journal"},{"key":"58205_CR55","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","year":"1996","unstructured":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043\u20131065 (1996).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58205-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58205-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58205-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:32:43Z","timestamp":1670308363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58205-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58205"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58205-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"12 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1560"}}